Studies have shown that the protein expressions of ZO-1 and occludin are reduced in adenocarcinoma of the digestive tract and that the intestinal barrier is impaired, followed by increased intestinal permeability (Han X. et al., 2019). This evidence concerns the gene OCLN and adenocarcinoma.